FEND

Sensory Cloud, the company behind FEND is transitioning.

Since we invented FEND in 2020, our company has evolved into a clinical research organization focused on developing therapeutics to treat chronic cough and other inflammatory conditions of the upper airways. Going forward, we will operate under a new name, SC Therapeutics.

As our therapeutic program advances, we have sunset the FEND consumer business as of June 30, 2026. We will continue to offer customer support through our regular channels until July 31, 2026.

To learn more about SC Therapeutics and the work ahead, please visit www.sctherapeutic.com

Thank you to everyone who supported FEND over the past years. Your trust made this chapter possible.